Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Colon cancer
Trial Type:  Prevention
Trial Status:  Active
Sponsor of Trial:  NCI
Results 1-9 of 9 for your search:
Start Over
S0820, Adenoma and Second Primary Prevention Trial
Phase: Phase III
Type: Prevention
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: S0820, U10CA037429, NCI-2012-02067, NCT01349881
Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Prevention
Status: Active
Age: 40 to 120
Sponsor: NCI
Protocol IDs: NCI-2009-01192, 09-001758, MC054A, R01-CA-113681, P30CA015083, NCT00983580
Fish Oil Supplementation, Nutrigenomics and Colorectal Cancer Prevention
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 79
Sponsor: NCI, Other
Protocol IDs: 11165, R01CA160938, NCT01661764
Trial of Linaclotide to Demonstrate Colorectal Bioactivity in Health Volunteers
Phase: Phase I
Type: Prevention
Status: Approved-not yet active
Age: 18 to 65
Sponsor: NCI, Other
Protocol IDs: MAY2012-00-01, HHSN261201200032I, 13-829, NCT01912079
Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2014-00046, HHSN261201200034I, HHSN26100003; RFP B, MDACC-2013-0698, N01-CN-2012-00034, 2013-0698, MDA2013-01-02, N01CN00034, P30CA016672, NCT02052908
Berberine Chloride in Treating Patients With Ulcerative Colitis in Remission
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Approved-not yet active
Age: 18 to 70
Sponsor: NCI
Protocol IDs: NCI-2015-00173, NCI 2014-03-01, NWU2014-03-01, N01CN00035, P30CA060553, NCT02365480
Cruciferous Vegetable Intake and Histone Status in Screening Colonoscopy Patients
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention, Screening
Status: Active
Age: 50 to 75
Sponsor: NCI, Other
Protocol IDs: P01 CA090890, NCT01344330
FlaxFx, A Research Study of the Effects of Flaxseed Lignans on Colon Health
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 20 to 45
Sponsor: NCI, Other
Protocol IDs: FHCRC IR 7532, NCT01619020
ASPirin Intervention for the REDuction of Colorectal Cancer Risk
Phase: No phase specified
Type: Prevention
Status: Approved-not yet active
Age: 18 to 80
Sponsor: NCI, Other
Protocol IDs: 14-496, R01CA137178, NCT02394769
Start Over